Assets
+ Stark International Lux
History
2020: Purchase of business on production of BTG Specialty Pharmaceuticals antidotes
At the beginning of December, 2020 Boston Scientific announced sale of the division of BTG Specialty Pharmaceuticals which is engaged in production of antidotes. Business was purchased for $800 million Stark International Lux S.A.R.L. and SERP SAS company which are the child organizations of the European specialized pharmaceutical SERB group. Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |